The research project aims to optimise the design of a new spinal needle. The proposed design will enhance the quantity of the drug delivered inside the cerebral spinal fluid when there is a partial insertion of the needle eye. This will benefit patient health and management.
|Effective start/end date||7/11/22 → 7/05/23|
- Buckingham Medical Technologies Ltd: £60,668.00